Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?

Lauren A. Quinn, Sunaya H. Hirani, Thomas C. Williams, Ian P. Sinha
Breathe 2021 17: 210110; DOI: 10.1183/20734735.0110-2021
Lauren A. Quinn
1Queens University Belfast School of Medicine Dentistry and Biomedical Sciences, Belfast, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunaya H. Hirani
2Alder Hey Children's NHS Foundation Trust, Liverpool, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas C. Williams
3Dept of Paediatric Respiratory and Sleep Medicine, Royal Hospital for Children and Young People, Edinburgh, UK
4Department of Child Life and Health, University of Edinburgh, Edinburgh, UK
6Joint senior authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas C. Williams
Ian P. Sinha
2Alder Hey Children's NHS Foundation Trust, Liverpool, UK
5Division of Child Health, University of Liverpool, Liverpool, UK
6Joint senior authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: iansinha@liverpool.ac.uk
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 17 no. 4
DOI 
https://doi.org/10.1183/20734735.0110-2021

Published By 
European Respiratory Society
Print ISSN 
1810-6838
Online ISSN 
2073-4735
History 
  • Received July 15, 2021
  • Accepted July 27, 2021
  • Published online December 7, 2021.

Copyright & Usage 
Copyright ©ERS 2021 Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Lauren A. Quinn1,
  2. Sunaya H. Hirani2,
  3. Thomas C. Williams3,4,6 and
  4. Ian P. Sinha2,5,6⇑
  1. 1Queens University Belfast School of Medicine Dentistry and Biomedical Sciences, Belfast, UK
  2. 2Alder Hey Children's NHS Foundation Trust, Liverpool, UK
  3. 3Dept of Paediatric Respiratory and Sleep Medicine, Royal Hospital for Children and Young People, Edinburgh, UK
  4. 4Department of Child Life and Health, University of Edinburgh, Edinburgh, UK
  5. 5Division of Child Health, University of Liverpool, Liverpool, UK
  6. 6Joint senior authors
  1. iansinha{at}liverpool.ac.uk @wheezylikesund1 @williams_t_c
View Full Text

Article usage

Article usage: December 2021 to February 2023

AbstractFullPdf
Dec 2021035397
Jan 2022223779
Feb 20221201100
Mar 202228440
Apr 202214621
May 202206822
Jun 202205312
Jul 20220449
Aug 202232913
Sep 202228420
Oct 2022044917
Nov 202206624
Dec 20221204
Jan 20232308
Feb 20230329

Altmetrics

PreviousNext
Back to top
Vol 17 Issue 4 Table of Contents
Breathe: 17 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?
Lauren A. Quinn, Sunaya H. Hirani, Thomas C. Williams, Ian P. Sinha
Breathe Dec 2021, 17 (4) 210110; DOI: 10.1183/20734735.0110-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?
Lauren A. Quinn, Sunaya H. Hirani, Thomas C. Williams, Ian P. Sinha
Breathe Dec 2021, 17 (4) 210110; DOI: 10.1183/20734735.0110-2021
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Respiratory consequences of preterm birth
    • Babies with BPD are given palivizumab to prevent severe bronchiolitis
    • Does RSV bronchiolitis increase the risk of respiratory illness through the life course?
    • Does palivizumab reduce the risk of respiratory illness in childhood and adulthood?
    • Summary and future directions
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Subjects

  • Paediatric pulmonology
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Molecular TB diagnostics in limited-resource and high-burden areas
  • Self-management in chronic lung disease
Show more Viewpoint

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society